Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
Clinical trial NCT03532971 · COMPLETED
Trial details
- NCT number
- NCT03532971
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-30
- Primary completion
- 2020-09-14
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.